Brain Networks and Mobility Function: B-NET

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

192 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-07-20

Study Completion Date

2023-07-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Rapidly accumulating evidence indicates that the central nervous system (CNS) plays a pivotal role in mobility function with age-associated CNS changes strongly contributing to declining mobility. Studies linking the brain to mobility have used anatomical measures like brain volume and white matter integrity, and suggest that damage to the connecting fibers of the brain (white matter) is related to mobility impairment. Unfortunately, age-related structural white matter damage appears irreversible and only indirectly indicates the functional connectivity between brain regions. It is believed that functional brain network analyses have the potential to identify individuals that may benefit from interventions prior to the development of irreversible white matter lesions. The current project will assess both physical and cognitive function and integrate these variables with measures of brain network connectivity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Imaging Study of Automatic Movements

NCT00031382

Healthy

COMPLETED

Magnetic Resonance Imaging Studies of Motor and Thought Processes

NCT00001361

Cerebrovascular Disorder Healthy Movement Disorder +2 more

COMPLETED

Brain and Cognitive Reserve

NCT02819167

Brain Ischemia

COMPLETED NA

Blood Vessel Anatomy and Blood Flow Regulation

NCT05396287

Brain Blood Flow Healthy

ACTIVE_NOT_RECRUITING

CNS Changes Following Stroke

NCT04059276

Stroke

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Studies linking the brain to mobility have used anatomical measures like brain volume and white matter integrity, and suggest that damage to the connecting fibers of the brain (white matter) is related to mobility impairment. Unfortunately, age-related structural white matter damage appears irreversible and only indirectly indicates the functional connectivity between brain regions. The preliminary data show that directly assessed patterns of functional connectivity correlate with mobility function and can be changed by interventions that improve mobility function. It is not known how changes in CNS functional connectivity relate to changes in mobility, information critical for the design of interventions targeting CNS connectivity to improve mobility impairments. It is clear that structural connectivity underlies functional connectivity, and that structural brain lesions result in altered functional connections. B-NET will assess white matter (WM) disease burden and microstructural changes and relate these changes to functional brain network connectivity. We hypothesize that because sensory motor cortex community structure (SMC-CS) characterizes current brain organization, it will be associated with mobility function independently of anatomical damage markers. Such knowledge may permit earlier identification of persons at high risk for mobility decline and facilitate earlier and better targeted interventions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Central Nervous System White Matter Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Community-Dwelling Older Adults

The group will consist of 240 community-dwelling older adults with a range of mobility function based on the short physical performance battery (SPPB).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Community-dwelling adults aged ≥70 years
* Willing to provide informed consent; ability to communicate with study personnel.

Exclusion Criteria

* Serious or uncontrolled chronic disease such as:
* Cancer (stage 3 or 4) or having had radiation or chemotherapy in the past year
* Uncontrolled angina
* Heart failure (stage 3-4)
* Respiratory disease requiring the use of oxygen
* Uncontrolled endocrine/metabolic disease (fasting glucose \>250mg/dL)
* Liver failure (AST \> 40IU/L and/or ALT \> 44 IU/L)
* Renal failure requiring dialysis
* Clinically diagnosed neurologic diseases: Parkinson's disease; Amyotrophic Lateral Sclerosis (ALS); Multiple Sclerosis, prior stroke with residual effects lasting longer than 24hrs
* Diagnosis of schizophrenia, bipolar, or other psychotic disorder
* Diagnosis of Alzheimer's disease or evidence of impaired cognitive function
* Prior traumatic brain injury with residual deficits
* Unwilling or unable to have an MRI brain scan (see MRI screening form).
* Dependent on a walker or another person to ambulate.
* Plans to relocate in the next 2- 3 years.
* Single or double amputee
* Musculoskeletal impairments severe enough to preclude functional testing
* Participating in an exercise or cognitive enhancing intervention
* Any other reason the PI or study physician feels the participant would not adhere to the protocol

Minimum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes